Foresite Capital Management IV’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-677,143
| Closed | -$8.58M | – | 9 |
|
|
2022
Q2 | $8.58M | Sell |
677,143
-353,655
| -34% | -$4.48M | 2.31% | 6 |
|
|
2022
Q1 | $14.4M | Sell |
1,030,798
-175,000
| -15% | -$2.45M | 4.04% | 7 |
|
|
2021
Q4 | $34.9M | Hold |
1,205,798
| – | – | 7.18% | 6 |
|
|
2021
Q3 | $36.1M | Hold |
1,205,798
| – | – | 5.32% | 6 |
|
|
2021
Q2 | $32M | Sell |
1,205,798
-32,658
| -3% | -$866K | 4.32% | 7 |
|
|
2021
Q1 | $38.5M | Sell |
1,238,456
-1,109,348
| -47% | -$34.5M | 4.61% | 8 |
|
|
2020
Q4 | $77.2M | Sell |
2,347,804
-210
| -0% | -$6.91K | 8.39% | 5 |
|
|
2020
Q3 | $82M | Buy |
+2,348,014
| New | +$82M | 18.48% | 2 |
|